A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 247-253

  Sasaguri, Takakazu ^a   Arima, Nobuyuki ^a   Tanimoto, Akihide ^a   Shimajiri, Shohei ^a   Hamada, Tetsuo ^a   Sasaguri, Yasuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Atherosclerosis; Connective tissue degradation; Endopeptidases; Interleukin 4; Kawasaki's disease; MMP 1

Indexed keywords

COLLAGENASE; INTERLEUKIN 4;

AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN FIBROBLAST; VASCULAR SMOOTH MUSCLE;

AORTA; ARTERIOSCLEROSIS; CELLS, CULTURED; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 1; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 0032102168     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00296-7     Document Type: Article

References (30)

1. Ross R. Atherosclerosis: A defense mechanism gone awry. Am J Pathol. 143:1993;987-1002.
2. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
3. Sasaguri Y., Kato H. Regression of aneurysms in Kawasaki disease: A pathological study. Pediatrics. 100:1982;225-231.
4. Yanagi H., Sasaguri Y., Sugama K., Morimatsu M., Nagase H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis. 91:1992;207-216.
5. Sasaguri Y., Murahashi N., Sugama K., Kato S., Hiraoka K., Satoh T., Isomoto H., Morimatsu M. Development-related changes in matrix metalloproteinse expression in human aortic smooth muscle cells. Lab Invest. 71:1994;261-269.
6. Satoh T., Sugama K., Matsuo A., Kato S., Ito S., Hatanaka M., Sasaguri Y. Histamine as an activator of cell growth and extracellular matrix reconstruction for human vascular smooth muscle cells. Atherosclerosis. 110:1994;53-61.
7. Takagishi T., Sasaguri Y., Nakano R., Arima N., Tanimoto A., Fukui H., Morimatsu M. Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am J Pathol. 146:1995;981-988.
8. Munro J.M., van der Walt J.D., Munro C.S., Chalmers J.A.C., Cox E.L. An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol. 18:1987;375-380.
9. Emerson E.E., Robertson A.L. T lymphocytes in aortic and coronary intimas: Their potential role in atherogenesis. Am J Pathol. 130:1988;369-376.
10. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
11. Gordon J.R., Burd P.R., Galli S.J. Mast cells as a source of multifunctional cytokines. Immunol Today. 11:1990;458-464.
12. Paul W.E. Interleukin-4: A prototypic immunoregulatory lymphokine. Blood. 77:1991;1859-1870.
13. Dechanet J., Briolay J., Rissoan M.C., Chomarat P., Galizzi J.P., Banchereau J., Miossec P. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J Immunol. 151:1993;4908-4917.
14. Postlethwaite A., Holness M.A., Katai H., Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 90:1992;1479-1485.
15. Lacraz S., Nicod L., Rochemonteix B.G., Baumberger C., Dayer J.M., Welgus H. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest. 90:1992;382-388.
16. Kato S., Sasaguri Y., Morimatsu M. Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimal smooth muscle cells. Biochem Mol Biol Int. 31:1993;239-248.
17. Zenmyo M., Hiraoka K., Komiya S., Morimatsu M., Sasaguri Y. Histamine stimulated production of matrix metalloproteinase 1 by human rheumatoid synovial fibroblasts is mediated by histamine H1-receptors. Virchows Arch. 427:1995;437-444.
18. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131-138.
19. Forman M.B., Oartes J.A., Robertson D., Robertson R.M., Roberts L.J., Virmani R. Increased adventitial mast cells in a patient with coronary spasm. New Engl J Med. 313:1985;1138-1141.
20. Atkinson J.B., Harlan C.W., Harlan G.C., Virmani R. The association of mast cell and atherosclerosis: A morphologic study of early atherosclerotic lesions in young people. Hum Pathol. 25:1994;154-159.
21. van der Wal A.C., Das P.K., van der Berg D.B., van der Loos C.M., Becker A.E. Atherosclerotic lesions in humans: In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 61:1989;166-170.
22. Xu Q., Oberhuber G., Gruschwitz M., Wick G. Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged specimens. Clin Immunol Immunopathol. 56:1990;344-359.
23. Shimokama T., Haraoka S., Watanabe T. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. Mod Pathol. 4:1991;101-107.
24. Watanabe T., Shimokama T., Haraoka S., Kishikawa H.T. lymphocytes in atherosclerotic lesions. Ann New York Acad Sci. 748:1995;40-55.
25. Hansson G.K., Holm J., Jonsasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 135:1989;169-175.
26. Hansson G.K., Holm J., Holm S., Fotev Z., Hedrich H.-J., Fingerle J. Lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA. 88:1991;10530-10534.
27. Fyfe A.I., Qiao J.-H., Lusis A.J. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest. 94:1994;2516-2520.
28. Haraoka S., Shimokama T., Watanabe T. Participation of T lymphocytes in atherogenesis: Sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolaemia using en face double immunostaining. Virchows Arch. 426:1995;307-315.
29. Prontera C., Crescenzi G., Rotillo D. Inhibition by interleukin 4 of stromelysin expression in human fibroblasts: Role of PKC. Exp Cell Res. 224:1996;183-188.
30. Hart P.H., Vitti G.F., Burgess D.R., Whitty G.A., Piccoli D.S., Hamilton J.A. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA. 86:1989;3803-3807.